Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

Anti-androgens can help reduce the effects of male hormones on the skin.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Dutasteride and finasteride affect different cell types differently.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Sebocytes play a key role in controlling androgen levels in human skin.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Lowering testosterone speeds up wound healing in male mice.

Hair loss in women may have causes other than hormones.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Longer CAG repeats in gene linked to more severe hair loss in females.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.